Ketamine and Psilocybin Update in Treatment-Resistant Depression
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.
Stay updated with breaking news from Pathways Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.
St. Claire HealthCare (SCH), on behalf of the Northeast Kentucky Substance Use Response Coalition, is pleased to announce they have been awarded a $300,000 Core Priorities Grant by the Pallottine Foundation of Huntington, West Virginia. SCH and the Coalition were the only recipients of this grant in Kentucky and only one of four recipients between Kentucky, Ohio, and West Virginia.
Novant Health Foundation grant will connect Wilmington violence victims with resources they need.
/PRNewswire/ -- Policy Pathways will host its Fourth Annual Fall Celebration on Thursday, October 20, 2022, from 6 – 8:00 p.m. (EST). The virtual event honors...
HUNTINGTON — The Pallottine Foundation of Huntington has awarded Pollen8, Recovery Point West Virginia, St. Claire HealthCare and Unlimited Future Inc. with grants totaling over $1.1 million through its Core